Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression.
Allard P, Tagliaferri L, Weru V, Cario H, Lobitz S, Grosse R, Bleeke M, Oevermann L, Hakimeh D, Jarisch A, Kopp-Schneider A, Kulozik AE, Kunz JB; German Sickle Cell Disease Study Group. Allard P, et al. Among authors: weru v. Eur J Haematol. 2024 Jun 30. doi: 10.1111/ejh.14259. Online ahead of print. Eur J Haematol. 2024. PMID: 38946051
Capturing COPD heterogeneity: anomaly detection and parametric response mapping comparison for phenotyping on chest computed tomography.
Almeida SD, Norajitra T, Lüth CT, Wald T, Weru V, Nolden M, Jäger PF, von Stackelberg O, Heußel CP, Weinheimer O, Biederer J, Kauczor HU, Maier-Hein K. Almeida SD, et al. Among authors: weru v. Front Med (Lausanne). 2024 Mar 1;11:1360706. doi: 10.3389/fmed.2024.1360706. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38495118 Free PMC article.
The prognostic value of [18F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria.
Sachpekidis C, Weru V, Kopp-Schneider A, Hassel JC, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Among authors: weru v. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2699-2714. doi: 10.1007/s00259-023-06243-y. Epub 2023 Apr 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 37099131 Free PMC article.
Test-retest, inter- and intra-rater reproducibility of size measurements of focal bone marrow lesions in MRI in patients with multiple myeloma.
Wennmann M, Grözinger M, Weru V, Hielscher T, Rotkopf LT, Bauer F, Gnirs R, Nonnenmacher T, Sauer S, Goldschmidt H, Weinhold N, Bonekamp D, Weber TF, Schlemmer HP, Delorme S. Wennmann M, et al. Among authors: weru v. Br J Radiol. 2023 Apr 1;96(1145):20220745. doi: 10.1259/bjr.20220745. Epub 2023 Apr 12. Br J Radiol. 2023. PMID: 37001052 Free PMC article.
Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs.
Samarin J, Fabrowski P, Kurilov R, Nuskova H, Hummel-Eisenbeiss J, Pink H, Li N, Weru V, Alborzinia H, Yildiz U, Grob L, Taubert M, Czech M, Morgen M, Brandstädter C, Becker K, Mao L, Jayavelu AK, Goncalves A, Uhrig U, Seiler J, Lyu Y, Diederichs S, Klingmüller U, Muckenthaler M, Kopp-Schneider A, Teleman A, Miller AK, Gunkel N. Samarin J, et al. Among authors: weru v. Redox Biol. 2023 Jun;62:102639. doi: 10.1016/j.redox.2023.102639. Epub 2023 Feb 23. Redox Biol. 2023. PMID: 36958250 Free PMC article.
17 results